Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...
MedPage Today on MSN
Add-On Multicancer Early Detection Test Promising Across Various Cancer Types
BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...
Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...
Complementary value of a digital pathology biomarker to post-surgery circulating tumor DNA in risk stratification of stage III colon cancer patients receiving adjuvant chemotherapy. This is an ASCO ...
Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction Model Cell-free DNA (cfDNA) and matched tumor sample from patients with BTC were analyzed using targeted ...
CNW/ - Medcan, a global leader in proactive health and wellness, announced the Canadian launch of the Galleri® multi-cancer early detection (MCED) test ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback